Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
The Vacuolar H+ ATPase α3 Subunit Negatively Regulates Migration and Invasion of Human Pancreatic Ductal Adenocarcinoma Cells
Mette Flinck et al.
CELLS (2020)
The Clinician's Guide to Proton Pump Inhibitor Related Adverse Events
Evan Elias et al.
DRUGS (2019)
Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression
Bin Zhang et al.
CANCER LETTERS (2019)
Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site
Srishti Singh et al.
MOLECULES (2018)
Crystal structures of the gastric proton pump
Kazuhiro Abe et al.
NATURE (2018)
Omeprazole Inhibits Cell Proliferation and Induces G0/G1 Cell Cycle Arrest through Up-regulating miR-203a-3p Expression in Barrett's Esophagus Cells
Yichao Hou et al.
FRONTIERS IN PHARMACOLOGY (2018)
Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer
Jin Sung Koh et al.
CELL AND BIOSCIENCE (2018)
Esomeprazole Increases Airway Surface Liquid pH in Primary Cystic Fibrosis Epithelial Cells
Livia Delpiano et al.
FRONTIERS IN PHARMACOLOGY (2018)
Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy
Elisabetta Iessi et al.
METABOLITES (2018)
Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H, K-ATPase
Jin-Young Min et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Cancer cell behaviors mediated by dysregulated pH dynamics at a glance
Katharine A. White et al.
JOURNAL OF CELL SCIENCE (2017)
Tumour acidosis: from the passenger to the driver's seat
Cyril Corbet et al.
NATURE REVIEWS CANCER (2017)
Alternating pH landscapes shape epithelial cancer initiation and progression: Focus on pancreatic cancer
Stine F. Pedersen et al.
BIOESSAYS (2017)
Proton pump inhibitors on pancreatic cancer risk and survival
Malcolm D. Kearns et al.
CANCER EPIDEMIOLOGY (2017)
pH-sensitive K+ channel TREK-1 is a novel target in pancreatic cancer
Daniel R. P. Sauter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression
Carmelo Scarpignato et al.
BMC MEDICINE (2016)
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
Faiyaz Notta et al.
NATURE (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines
Ilya Kovalenko et al.
PLOS ONE (2016)
Regulation of Cellular Identity in Cancer
Nilotpal Roy et al.
DEVELOPMENTAL CELL (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane
Mehdi Damaghi et al.
NATURE COMMUNICATIONS (2015)
Proton Pump Inhibitors Inhibit Pancreatic Secretion: Role of Gastric and Non-Gastric H+/K+-ATPases
Jing Wang et al.
PLOS ONE (2015)
hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications
Olivia Crociani et al.
CLINICAL CANCER RESEARCH (2014)
The vacuolar-type H+-ATPase at a glance - more than a proton pump
Michelle E. Maxson et al.
JOURNAL OF CELL SCIENCE (2014)
Acidic extracellular microenvironment and cancer
Yasumasa Kato et al.
CANCER CELL INTERNATIONAL (2013)
Use of the Proton Pump Inhibitor Pantoprazole to Modify the Distribution and Activity of Doxorubicin: A Potential Strategy to Improve the Therapy of Solid Tumors
Krupa J. Patel et al.
CLINICAL CANCER RESEARCH (2013)
Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway
Shuling Huang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho-LRP6 expression in Wnt/β-catenin signaling
Weidong Shen et al.
ONCOLOGY REPORTS (2013)
Acid-base transport in pancreas-new challenges
Ivana Novak et al.
FRONTIERS IN PHYSIOLOGY (2013)
Disrupting proton dynamics and energy metabolism for cancer therapy
Scott K. Parks et al.
NATURE REVIEWS CANCER (2013)
Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study
M. C. Bradley et al.
BRITISH JOURNAL OF CANCER (2012)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
Systemic Buffers Inhibit Carcinogenesis in TRAMP Mice
Arig Ibrahim-Hashim et al.
JOURNAL OF UROLOGY (2012)
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work
Robert J. Gillies et al.
NATURE REVIEWS CANCER (2012)
Pancreatic Bicarbonate Secretion Involves Two Proton Pumps
Ivana Novak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer
Chuhan Chung et al.
LABORATORY INVESTIGATION (2011)
pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity
Angelo De Milito et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
Ian F. Robey et al.
CANCER RESEARCH (2009)
The gastric HK-ATPase: structure, function, and inhibition
Jai Moo Shin et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2009)
Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species
Angelo De Milito et al.
CANCER RESEARCH (2007)
Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis:: deactivation is induced by matrigel and N-acetylcysteine
R Jesnowski et al.
LABORATORY INVESTIGATION (2005)
The non-gastric H,K-ATPase is oligomycin-sensitive and can function as an H+,NH4+-ATPase
HGP Swarts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells
M Yeo et al.
CLINICAL CANCER RESEARCH (2004)
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs
F Luciani et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
A proton-pump inhibitor expedition: The case histories of omeprazole and esomeprazole
L Olbe et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Share Paper
